Skip to main content
Home

Leading research for life changing results

  • Our Role & Impact
    • About HMRI
    • Our Team
    • Research Funded through HMRI
    • Our Foundations
      • HMRI Foundation
      • HMRI Sydney Foundation
      • HCRF
      • HTRF
      • Borne HMRI
    • Awards and Recognition
      • Researcher Awards
      • HMRI Exceptional Service
    • Our Partnerships
    • Governance
    • Careers
    • Contact Us
  • Medical Research
    • Research
    • Researchers
    • Participate In Research
    • Coronavirus (COVID-19)
  • Support HMRI
    • Donate Online
    • Your Impact
    • Ways to Donate
    • Fundraise
    • Bequests
    • Volunteer
    • Company Donors
  • For Researchers
    • HMRI Connect Researcher Intranet
    • Services for Researchers
      • Clinical Trials Unit
      • Bioinformatics & Special Applications Support
      • Clinical Research Design and Statistics
      • Health Research Economists
      • Funding Support
      • Research Study Recruitment
      • Clinical Trials Roadmap
    • Facilities and Equipment for Researchers
    • Register to be a HMRI Researcher
  • Events
    • Upcoming Events
  • News & Articles
  1. Home
  2. Search Results

Search Results

  • All (27) Remove All (27) filter
  • News & Articles (11)
  • Research (11)
  • Researcher Profiles (3)
  • For Researchers (1)
  • General (1)

Search found 27 items

All
MERINO2: A randomised controlled trial comparing two different antibiotics for blood stream infections caused by the 'ESCaPM' group of antibiotic resistant Gram negative bacteria
Category: Research
... over 45 cases at JHH annually.  ESCaPMs are resistant to most common antibiotics, and the best treament for them is not known. Current ... guidelines recommend using meropenem, one of the most powerful antibiotics in our armamentarium and the last line of defence against antbiotic resistant bacteria. Since overuse of particular antibiotics can lead to bacterial resistance (at a community or hospital ...
Jodie Simpson
Category: Researcher Profiles
... disease that target neutrophilic inflammation such as macrolide antibiotics. Identifying the mechanisms of neutrophilic inflammation - ... first randomised controlled trials of macrolide therapy (a type of antibiotics) for patients with difficult asthma and more recently for ... project grant in an Australia-wide multicentre study of macrolide antibiotics in asthma (AMAZES) which is nearing completion. At the time ...
Asthmatics sought for AMAZing antibiotic trial
Category: News & Articles
A national study investigating the use of antibiotics as a potential therapy for chronic asthma attacks is ... years after it commenced. A national study investigating the use of antibiotics as a potential therapy for chronic asthma attacks is ... tablet. “We showed in a previous study of 45 people that macrolide antibiotics can reduce inflammation and improve quality of life for ...
Research to help patients breathe easy on World Asthma Day
Category: News & Articles
New research is underway to test the effectiveness of combining antibiotics with commonly used treatments to help people with asthma ... New research is underway to test the effectiveness of combining antibiotics with commonly used treatments to help people with asthma ... Day New research is underway to test the effectiveness of combining antibiotics with current treatments to help people with asthma better ...
Peter Gibson
Category: Researcher Profiles
... to develop a new treatment for non-eosinophilic asthma with macrolide antibiotics. Eosinophils are a form of white blood cells in the immune ...
Investigating the role of microbiomes in COPD
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema. Project ... COPD. Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which ... the development of COPD that we may be able to target with specific antibiotics. In addition, we have found 2 other bacteria, which have the ...
Investigating the role of microbiomes in COPD
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema. Project ... COPD. Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which ... the development of COPD that we may be able to target with specific antibiotics. In addition, we have found 2 other bacteria, which have the ...
Investigating the role of microbiomes in COPD
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema.   Project ... COPD. Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which ... the development of COPD that we may be able to target with specific antibiotics. In addition, we have found 2 other bacteria, which have the ...
Investigating the role of microbiomes in COPD
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema. ... COPD. Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which ... of COPD, as well as during standard treatments with steroids and antibiotics in mice. 2. Assess for the same changes in gut microviomes ...
Leading the defence against superbugs
Category: News & Articles
... As one of the greatest health challenges facing humanity, the antibiotics currently used to treat infections are becoming increasingly ... OUTBREAK (One-health Understanding Through Bacterial REsistance to Antibiotics Knowledge) will be led by the University of Technology ...
  • 1
  • 2
  • 3
  • Contact us
  • View Research & Diseases
  • News & Articles
  • Site Map
  • Privacy Policy
  • ​
  • HUNTER MEDICAL RESEARCH INSTITUTE ABN 27 081 436 919 | Phone (02) 4042 0000 |  Donation Hotline 1300 993 822
  •  
  • Copyright © Hunter Medical Research Institute 2022
  •  
  • Tata Consultancy Services